June has seen a slew of executive hires, promotions, exits and layoffs across the healthcare sector. For example, CVS Health and HCA Healthcare welcomed new executives, and Ascension and Optum Health announced that their CEOs are departing. There were also layoffs at organizations including Providence, UCSF Health and Vanderbilt University Medical Center. The post Healthcare…
AbbVie is acquiring Capstan Therapeutics, a startup with technology that enables in vivo engineering of immune cells. The University of Pennsylvania spinout’s lead program recently began a Phase 1 test as a potential treatment for B cell-mediated autoimmune disorders. The post AbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation Pipeline…
NASA Recognizes Crothall’s Joe Irons for Prestigious Safety Award Crothall Unit Director Joseph Irons is widely known at the National Aeronautics and Space Administration (NASA) facility in West Virginia as a person who finds a solution to nearly any problem. To recognize his outstanding work, Irons recently received NASA’s prestigious “Yes, If,” award, a coin…
In this episode, we’re joined by Julia Lasater, management consulting senior analyst at Accenture, and Amani Bright, senior program manager at Springboard Enterprises. They discuss the key takeaways of their recent women’s health report. The post MedCity FemFwd: Inside Springboard Enterprises and Accenture’s New Women’s Health Report appeared first on MedCity News.
[Sponsored] Everyone has a different idea or method for losing weight. These leaders in nutrition offer guidance on finding the right fit. The post The Best Group Nutrition Programs for Weight Loss: A Comprehensive Guide appeared first on MedCity News.
We have an imperative to restore trust in science and continue to advance equity, and we have the means to do so with technology, data connections, and dedicated healthcare professionals. It is also critically important to preserve our expert scientific and public health resources so they can ensure we are prepared for the next crisis. The…
A delayed diagnosis can cause a progression in severity (from mild to moderate to severe), increased suffering for the entire family, as well as enhance the risk of long-term neurological damage and the time it takes for them to heal. The post The Hidden Autoimmune Disorder Affecting Our Kids: Understanding PANS and PANDAS appeared first…
Some hospitals are turning to AI to help manage declining revenue and financial pressure, but one expert says success depends on more than just buying new tech. Prashant Karamchandani of Chartis urged health systems to pair AI adoption with foundational work like change management, continuous improvement and operating model redesign. The post Why Hospitals Must…
Employers are advocating for changes to the 340B Drug Pricing Program, arguing that it allows hospitals to “buy low and sell high” by purchasing discounted medications and charging insured patients full price. The post Why Employers Think the 340B Program Needs Reform appeared first on MedCity News.
Neopharmed Gentili is acquiring European rights to Orladeyo, bringing the Italy-based pharmaceutical company into rare disease. BioCryst’s Orladeyo is approved for treating patients with the rare disease hereditary angioedema. The post BioCryst Pharma Sells European Business for Rare Disease Drug in $250M Deal appeared first on MedCity News.